Skip to main content
. 2018 May 24;103(9):1549–1556. doi: 10.3324/haematol.2018.192419

Figure 1.

Figure 1.

Cumulative incidence of arterial thromboembolism (ATE) in patients with cancer. For estimation we used a competing risk cumulative incidence estimator. Venous thromboembolism (VTE) and death-from-any-cause were considered as competing risk events. The dashed line represents 95% confidence bands.